Literature DB >> 9569018

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.

H Hiyama1, A Iavarone, S A Reeves.   

Abstract

The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G1/S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identified E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the -215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the -215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G1/S boundary. The significance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F-induced levels of p21 protein during the G1/ S transition is consistent with the recent findings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569018     DOI: 10.1038/sj.onc.1201667

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Distinct cellular factors regulate the c-myb promoter through its E2F element.

Authors:  M R Campanero; M Armstrong; E Flemington
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 2.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias.

Authors:  Kensuke Kojima; Jared K Burks; Janine Arts; Michael Andreeff
Journal:  Mol Cancer Ther       Date:  2010-08-24       Impact factor: 6.261

4.  Comprehensive assessment of P21 polymorphisms and lung cancer risk.

Authors:  Yi Young Choi; Hyo-Kyung Kang; Jin Eun Choi; Jin Sung Jang; Eun Jin Kim; Sung Ick Cha; Won Kee Lee; Sin Kam; Chang Ho Kim; Sung Beom Han; Tae Hoon Jung; Jae Yong Park
Journal:  J Hum Genet       Date:  2007-11-28       Impact factor: 3.172

5.  Cell-derived micro-environment helps dental pulp stem cells promote dental pulp regeneration.

Authors:  Xuexin Zhang; Hui Li; Jingjing Sun; Xiangyou Luo; Hefeng Yang; Li Xie; Bo Yang; Weihua Guo; Weidong Tian
Journal:  Cell Prolif       Date:  2017-07-25       Impact factor: 6.831

6.  Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response.

Authors:  Martin V Bennetzen; Dorthe Helena Larsen; Christoffel Dinant; Sugiko Watanabe; Jiri Bartek; Jiri Lukas; Jens S Andersen
Journal:  Cell Cycle       Date:  2013-05-01       Impact factor: 4.534

7.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 9.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

10.  E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.

Authors:  Shweta Tyagi; Winship Herr
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.